Related references
Note: Only part of the references are listed.Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
Allan C. Skanes et al.
CANADIAN JOURNAL OF CARDIOLOGY (2012)
Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John J. You et al.
CHEST (2012)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association
A. John Camm et al.
EUROPACE (2012)
Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation
P. R. Sinnaeve et al.
JOURNAL OF INTERNAL MEDICINE (2012)
New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation
A. Tripodi et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter
John A. Cairns et al.
CANADIAN JOURNAL OF CARDIOLOGY (2011)
Antithrombotic Therapy in Atrial Fibrillation - Evaluation and Positioning of New Oral Anticoagulant Agents
Satoshi Ogawa et al.
CIRCULATION JOURNAL (2011)
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Margaret C. Fang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2006 WRITING COMMITTEE MEMBERS Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Valentin Fuster et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
J. B. Olesen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage A Longitudinal Population-Based Study
Juha Huhtakangas et al.
STROKE (2011)
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Larry B. Goldstein et al.
STROKE (2011)
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
Arlene M. Gallagher et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study
Jonas Bjerring Olesen et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
Jonas Bjerring Olesen et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPACE (2010)
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W
Raffaele De Caterina et al.
EUROPEAN HEART JOURNAL (2010)
The Effect and Safety of the Antithrombotic Therapies in Patients with Atrial Fibrillation and CHADS2 Score 1
Byung Ho Lee et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2010)
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Lars Wallentin et al.
LANCET (2010)
Newly Identified Events in the RE-LY Trial
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
New anticoagulants for the prevention of venous thromboembolism
Cecilia Becattini et al.
Drug Design Development and Therapy (2010)
Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation? The ATRIA Study
Daniel E. Singer et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
David J. Gladstone et al.
STROKE (2009)
Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
Christopher Ll. Morgan et al.
THROMBOSIS RESEARCH (2009)
Antithrombotic and thrombolytic therapy
Jack Hirsh et al.
CHEST (2008)
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Stuart J. Connolly et al.
CIRCULATION (2008)
Warfarin therapy: in need of improvement after all these years
Stephen E. Kimmel
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
A. M. Gallagher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Warfarin for atrial fibrillation in community-based practise
A. J. Rose et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
Jonathan Mant et al.
LANCET (2007)
Death and disability from warfarin-associated intracranial and extracranial hemorrhages
Margaret C. Fang et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
M. L. Flaherty et al.
NEUROLOGY (2007)
The unchanging incidence and case-fatality of stroke in the 1990s - A population-based study
Dawn Kleindorfer et al.
STROKE (2006)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
S. Connolly et al.
LANCET (2006)
Translating the results of randomized trials into clinical practice - The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation
EM Hylek et al.
STROKE (2006)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text
Valentin Fuster et al.
EUROPACE (2006)
Systematic overview of warfarin and its drug and food interactions
AM Holbrook et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population
M Jones et al.
HEART (2005)
Lifetime risk for development of atrial fibrillation - The Framingham Heart Study
DM Lloyd-Jones et al.
CIRCULATION (2004)
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
MC Fang et al.
ANNALS OF INTERNAL MEDICINE (2004)
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
EM Hylek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Predictors of warfarin use among Ohio Medicaid patients with new-onset nonvalvular atrial fibrillation
JA Johnston et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Management of atrial fibrillation:: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications
V Frykman et al.
EUROPEAN HEART JOURNAL (2001)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Why do patients with atrial fibrillation not receive warfarin?
TJ Bungard et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
